Home Apthera

Apthera

acquired
-
Cancer Immunotherapy Developer
Basic
Enterprise Profile

Basic Information

Apthera, Inc. is a biotechnology company that develops and produces peptide-based cancer immunotherapy solutions. It provides products for the treatment of breast cancer and prostate cancer.
Apthera, Inc.
Arizona,United States of America
less than 15 people
January 01, 2005
--
mwschwartz@apthera.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Immunological Techniques
Concept
Therapeutic Products Breast Cancer Prostate Cancer
Application Scenarios
Innovative Drugs